Login / Signup
Genetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk: A Mendelian Randomization Study.
Bowen Tang
Yunzhang Wang
Xia Jiang
Madhav Thambisetty
Luigi Ferrucci
Kristina Johnell
Sara Hägg
Published in:
Neurology (2022)
Genetic variation in sulfonylurea targets was associated with a lower risk of AD, and future studies are warranted to clarify the underlying mechanistic pathways between sulfonylureas and AD.
Keyphrases
</>
current status
case control